nach oben

Erschienen in:

11.12.2018 | Affektive Störungen | Zertifizierte Fortbildung

Dritte Welle der Verhaltenstherapie

Klinische Wirksamkeit der Schematherapie bei Depressionen

verfasst von: Dr. med. Martin L. Rein, Dr. med. David Höhn, Prof. Dr. Dr. Martin E. Keck

Erschienen in: NeuroTransmitter | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Sowohl zur Akutbehandlung als auch zur Rezidivprophylaxe depressiver Störungen gilt die kognitive Verhaltenstherapie (KVT) aus psychotherapeutischer Sicht als Goldstandard. Jedoch erleidet ungefähr die Hälfte der Patienten trotz akutem Ansprechen innerhalb von zwei Jahren ein Rezidiv. Schematherapie, ein neues, integratives psychotherapeutisches Verfahren der „dritten Welle“ der Verhaltenstherapie, nimmt Risikofaktoren, die mit einem negativen therapeutischen Outcome assoziiert wurden, ausdrücklich in den Fokus der Behandlung. Das Verfahren wurde ursprünglich zur Behandlung von KVT-Non-Respondern und Patienten mit überdauernden Lebensproblemen und Persönlichkeitsstörungen entwickelt, und eine Anwendung auch bei Achse-I-Störungen wie der Major Depression erscheint zielführend.

Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys. JAMA [Internet]. 2004 [cited 2017 Apr 18];291:2581. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15173149CrossRef

Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry [Internet]. 1994;51:8–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8279933CrossRef

Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA [Internet]. 2003 [cited 2014 Nov 30];289:3095–105. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12813115CrossRef

Levinson DF. The Genetics of Depression: A Review. Biol Psychiatry [Internet]. 2006 [cited 2017 Apr 12];60:84–92. Available from: http://www.sciencedirect.com/science/article/pii/S0006322305010139CrossRef

Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med [Internet]. 2010 [cited 2018 Jan 28];40:899–909. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19719899CrossRef

Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med [Internet]. Public Library of Science; 2013 [cited 2014 Jul 14];10:e1001547. Available from: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001547

RC K. Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys. JAMA [Internet]. American Medical Association; 2004 [cited 2017 Apr 18];291:2581. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.291.21.2581CrossRef

Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England) [Internet]. HM Stationery Office, London; 2012 [cited 2017 Apr 24];380:2197–223. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23245608CrossRef

Üstün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry [Internet]. 2004 [cited 2017 Apr 18];184. Available from: http://bjp.rcpsych.org/content/184/5/386.short

10.

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (London, England) [Internet]. Elsevier; 2018 [cited 2018 Apr 5];0. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29477251

11.

Huhn M, Tardy M, Spineli LM, Kissling W, Förstl H, Pitschel-Walz G, et al. Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders. JAMA Psychiatry [Internet]. American Medical Association; 2014 [cited 2018 Apr 5];71:706. Available from: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2014.112

12.

Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O’Reardon JP, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry [Internet]. 2005;62:417–22. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15809409CrossRef

13.

Guidi J, Tomba E, Fava GA. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature. Am J Psychiatry [Internet]. 2016 [cited 2016 Feb 16];173:128–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26481173CrossRef

14.

Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy’s effects. J Consult Clin Psychol [Internet]. NIH Public Access; 2007 [cited 2017 Dec 15];75:475–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17563164

15.

Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet [Internet]. 2003 [cited 2018 Jan 28];361:653–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12606176CrossRef

16.

Glue P, Donovan MR, Kolluri S, Emir B. Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders. Aust New Zeal J Psychiatry [Internet]. 2010 [cited 2018 Jan 28];44:697–705. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20636190CrossRef

17.

Guidi J, Fava GA, Fava M, Papakostas GI. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med [Internet]. 2011 [cited 2018 Jan 28];41:321–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20444307CrossRef

18.

Hansen R, Gaynes B, Thieda P, Gartlehner G, Deveaugh-Geiss A, Krebs E, et al. Meta-analysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants. Psychiatr Serv [Internet]. 2008 [cited 2018 Jan 28];59:1121–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18832497CrossRef

19.

Segal Z V., Bieling P, Young T, MacQueen G, Cooke R, Martin L, et al. Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression. Arch Gen Psychiatry [Internet]. 2010 [cited 2018 Jan 28];67:1256. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21135325CrossRef

20.

Richards D. Prevalence and clinical course of depression: A review. Clin Psychol Rev [Internet]. 2011 [cited 2018 Jan 28];31:1117–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21820991CrossRef

21.

Kessler RC. Epidemiology of depression. In: H. Gotlib & C. L. Hammen, editor. Handb Depress [Internet]. New York: Guilford Press.; 2002 [cited 2017 Dec 20]. p. 23–42. Available from: http://psycnet.apa.org/record/2002-01778-001

22.

Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry [Internet]. 1991 [cited 2016 Feb 28];52 Suppl:28–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1903134

23.

Kupfer DJ. Management of recurrent depression. J Clin Psychiatry [Internet]. 1993 [cited 2016 Apr 3];54 Suppl:29-33–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8444832

24.

Lépine J-P, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat [Internet]. 2011 [cited 2016 Mar 14];7:3–7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3131101&tool=pmcentrez&rendertype=abstract

25.

Keller MB, Hanks DL. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry [Internet]. 1995 [cited 2016 Apr 4];56 Suppl 6:22–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7649969

26.

27.

Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ [Internet]. British Medical Journal Publishing Group; 2015 [cited 2017 Dec 15];351:h6019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26645251CrossRef

28.

Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments. Can J Psychiatry [Internet]. SAGE PublicationsSage CA: Los Angeles, CA; 2013 [cited 2017 Dec 28];58:376–85. Available from: http://journals.sagepub.com/doi/10.1177/070674371305800702

29.

Keller MB. Long-term treatment of patients with recurrent unipolar major depression:evidence to clinical practice. CNS Spectr [Internet]. 2006;11:4–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17146412CrossRef

30.

Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med [Internet]. 1995;25:1171–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8637947CrossRef

31.

Renner F, Arntz A, Peeters FPML, Lobbestael J, Huibers MJH. Schema therapy for chronic depression: Results of a multiple single case series. J Behav Ther Exp Psychiatry [Internet]. Elsevier Ltd; 2016;51:66–73. Available from: http://dx.doi.org/10.1016/j.jbtep.2015.12.001CrossRef

32.

Reddy MS. Depression: the disorder and the burden. Indian J Psychol Med [Internet]. 2010;32:1–2. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3137804%7B%7B%7D%7B&%7D%7B%7D%7Dtool=pmcentrez%7B%7B%7D%7B&%7D%7B%7D%7Drendertype=abstractCrossRef

33.

Wiersma JE, Hovens JGFM, van Oppen P, Giltay EJ, van Schaik DJF, Beekman ATF, et al. The importance of childhood trauma and childhood life events for chronicity of depression in adults. J Clin Psychiatry [Internet]. 2009;70:983–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19653975CrossRef

34.

Kessler RC, McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, et al. Childhood adversities and adult psychopathology in the WHO world mental health surveys. Br J Psychiatry. 2010

35.

Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry [Internet]. 1996;153:1308–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8831439CrossRef

36.

Holmstrand C, Engström G, Träskman-Bendz L. Disentangling dysthymia from major depressive disorder in suicide attempters’ suicidality, comorbidity and symptomatology. Nord J Psychiatry [Internet]. 2008;62:25–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18389422CrossRef

37.

Pepper CM, Klein DN, Anderson RL, Riso LP, Ouimette PC, Lizardi H. DSM-III-R axis II comorbidity in dysthymia and major depression. Am J Psychiatry [Internet]. 1995;152:239–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7840358CrossRef

38.

Brown GW, Harris TO. Aetiology of anxiety and depressive disorders in an inner-city population. 1. Early adversity. Psychol Med [Internet]. 1993 [cited 2016 Apr 5];23:143–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8475202

39.

Brown GW, Craig TKJ, Harris TO, Handley R V., Harvey AL, Serido J. Child-specific and family-wide risk factors using the retrospective Childhood Experience of Care & Abuse (CECA) instrument: A life-course study of adult chronic depression — 3. J Affect Disord. 2007;103:225–36.CrossRef

40.

Klein DN, Arnow BA, Barkin JL, Dowling F, Kocsis JH, Leon AC, et al. Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depress Anxiety [Internet]. 2009 [cited 2016 Apr 5];26:701–10. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3528400&tool=pmcentrez&rendertype=abstractCrossRef

41.

Riso LP, Miyatake RK, Thase ME. The search for determinants of chronic depression: a review of six factors. J Affect Disord [Internet]. 2002;70:103–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12117622CrossRef

42.

Hayden EP, Klein DN. Outcome of Dysthymic Disorder at 5-Year Follow-Up: The Effect of Familial Psychopathology, Early Adversity, Personality, Comorbidity, and Chronic Stress. Am J Psychiatry [Internet]. 2001 [cited 2018 Jan 28];158:1864–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11691693CrossRef

43.

Hayashi Y, Okamoto Y, Takagaki K, Okada G, Toki S, Inoue T, et al. Direct and indirect influences of childhood abuse on depression symptoms in patients with major depressive disorder. BMC Psychiatry [Internet]. 2015 [cited 2017 Apr 11];15:244. Available from: http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-015-0636-1CrossRef

44.

Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am [Internet]. NIH Public Access; 2010 [cited 2017 Dec 27];33:537–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20599132

45.

Young JE. Cognitive therapy for personality disorders: A schema-focused approach (revised edition). Prof. Resour. Press. 1990.

46.

Beck AT. Depression: Clinical, Experimental and Theoretical Aspects [Internet]. University of Pensylvania Press; 1967 [cited 2016 Apr 5]. Available from: https://books.google.com/books?hl=de&lr=&id=6rigtdo0u2UC&pgis=1

47.

Rose; Abramson. Developmental Perspectives on Depression [Internet]. 1992 [cited 2016 Apr 5]. Available from: https://books.google.com/books?hl=de&lr=&id=Q_jCIkC9E2kC&pgis=1

48.

Clark DA, Beck AT. Scientific Foundations of Cognitive Theory and Therapy of Depression [Internet]. 1999 [cited 2016 Apr 5]. Available from: https://books.google.com/books?hl=de&lr=&id=UL4iDN2yGh4C&pgis=1

49.

Segal Z V, Shaw B, Safran J, Vella D, Moretti M, Baldwin M. Appraisal of the Self-Schema Construct in Cognitive Models of Depression. Psychol Bull. Taylor; 1988;103:147–62.CrossRef

50.

Schmidt NB, Joiner TE, Young JE, Telch MJ. The Schema Questionnaire: Investigation of Psychometric Properties and the Hierarchical Structure of a Measure of Maladaptive Schemas I. Cognit Ther Res [Internet]. 1995 [cited 2017 Oct 11];19. Available from: https://link.springer.com/content/pdf/10.1007%2FBF02230402.pdf

51.

McGinn L, Young JE. Schema-focussed Therapy. In: Salkovskis PM, Rachman S, editors. Front Cogn Ther [Internet]. Guilford; 1998 [cited 2018 Jan 28]. p. 554. Available from: https://books.google.com.au/books?hl=de&lr=&id=Koplpwwa24EC&oi=fnd&pg=PA1&dq=P.+Salkovskis+(Ed.),+Frontiers+of+cognitive+therapy.+New+York:+Guilford.&ots=4NgouFSPFy&sig=1pFlJribRkUClFOsenQK2OffjOg#v=onepage&q=P. Salkovskis (Ed.)%2C Frontiers of cognitive

52.

Young J. Cognitive therapy for personality disorders: A schema-focused approach (rev. 1994 [cited 2016 Apr 5]; Available from: http://psycnet.apa.org/psycinfo/1994-98188-000

53.

Young, Klosko W. Schema Therapy: A Practitioner’s Guide [Internet]. 2003 [cited 2016 Apr 5]. Available from: http://www.guilford.com/books/Schema-Therapy/Young-Klosko-Weishaar/9781593853723

54.

Holmes EA, Arntz A, Smucker MR. Imagery rescripting in cognitive behaviour therapy: Images, treatment techniques and outcomes. J Behav Ther Exp Psychiatry [Internet]. 2007 [cited 2018 Apr 6];38:297–305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18035331CrossRef

55.

Edwards D. Restructuring implicational meaning through memory-based imagery: Some historical notes. J Behav Ther Exp Psychiatry. 2007;38:306–16.CrossRef

56.

Lane RD, Ryan L, Nadel L, Greenberg L. Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: New insights from brain science. Behav Brain Sci [Internet]. 2015 [cited 2018 Mar 11];38:e1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24827452CrossRef

57.

Hayes AM, Castonguay LG, Goldfried MR. Effectiveness of targeting the vulnerability factors of depression in cognitive therapy. J Consult Clin Psychol [Internet]. 1996;64:623–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8698959CrossRef

58.

Cooper MJ, Rose KS, Turner H. Core beliefs and the presence or absence of eating disorder symptoms and depressive symptoms in adolescent girls. Int J Eat Disord [Internet]. Wiley Subscription Services, Inc., A Wiley Company; 2005 [cited 2017 Dec 20];38:60–4. Available from: http://doi.wiley.com/10.1002/eat.20157

59.

Welburn K, Dagg P. Schematic change as a result of an intensive group-therapy day-treatment programs. Psychotherapy [Internet]. 2000;37:189–95. Available from: http://psycnet.apa.org/journals/pst/37/2/189/CrossRef

60.

Harris AE, Curtin L. Parental perceptions, early maladaptive schemas, and depressive symptoms in young adults. Cognit Ther Res. 2002;26:405–16.CrossRef

61.

Simmons J, Cooper MJ, Drinkwater J, Stewart A. Cognitive Schemata in Depressed Adolescent Girls and Their Mothers. Behav Cogn Psychother [Internet]. Cambridge University Press; 2006 [cited 2017 Dec 20];34:219. Available from: http://www.journals.cambridge.org/abstract_S1352465805002766

62.

Shah R, Waller G. Parental style and vulnerability to depression: the role of core beliefs. J Nerv Ment Dis [Internet]. 2000;188:19–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10665456CrossRef

63.

van Vreeswijk MF, Spinhoven P, Eurelings-Bontekoe EHM, Broersen J. Changes in Symptom Severity, Schemas and Modes in Heterogeneous Psychiatric Patient Groups Following Short-term Schema Cognitive-Behavioural Group Therapy: A Naturalistic Pre-treatment and Post-treatment Design in an Outpatient Clinic. Clin Psychol Psychother [Internet]. 2014;21:29–38. Available from: http://doi.wiley.com/10.1002/cpp.1813CrossRef

64.

Sempértegui G a., Karreman A, Arntz A, Bekker MHJJ. Schema therapy for borderline personality disorder: A comprehensive review of its empirical foundations, effectiveness and implementation possibilities. Clin Psychol Rev [Internet]. Elsevier Ltd; 2013;33:426–47. Available from: http://dx.doi.org/10.1016/j.cpr.2012.11.006CrossRef

65.

Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med [Internet]. John Wiley & Sons; 2009 [cited 2017 May 5];6:e1000097. Available from: http://dx.plos.org/10.1371/journal.pmed.1000097CrossRef

66.

Alan Pearson, Faan F, White H, Hons FB, Bsn SS, Apostolo J, et al. A mixed-methods approach to systematic reviews. Int J Evid Based Healthc. 2015;13:121–131.CrossRef

67.

Gerber AJ, Kocsis JH, Milrod BL, Roose SP, Barber JP, Thase ME, et al. A Quality-Based Review of Randomized Controlled Trials of Psychodynamic Psychotherapy. Am J Psychiatry [Internet]. 2011 [cited 2018 Jan 28];168:19–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20843868CrossRef

68.

Kocsis JH, Gerber AJ, Milrod B, Roose SP, Barber J, Thase ME, et al. A new scale for assessing the quality of randomized clinical trials of psychotherapy. Compr Psychiatry [Internet]. Elsevier Inc.; 2010;51:319–24. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0010440X09000819CrossRef

69.

Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH. A Quality-Based Review of Randomized Controlled Trials of Cognitive-Behavioral Therapy for Depression: An Assessment and Metaregression. Am J Psychiatry [Internet]. 2012 [cited 2018 Jan 28];169:22–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22193528CrossRef

70.

Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Ann Intern Med [Internet]. American College of Physicians; 2001 [cited 2017 Jan 30];134:663. Available from: http://annals.org/article.aspx?doi=10.7326/0003-4819-134-8-200104170-00012

71.

Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med. 2008;148:295–309.CrossRef

72.

Jarlais D, Don C. Improving the Reporting Quality of Nonrandomized Evaluations of... Am J Public Health. 2004;94:361–6.PubMed

73.

Liebherz S, Schmidt N, Rabung S. How to assess the quality of psychotherapy outcome studies: A systematic review of quality assessment criteria. Psychother Res [Internet]. 2015;1–17. Available from: http://www.tandfonline.com/doi/full/10.1080/10503307.2015.1044763

74.

Malogiannis I a., Arntz A, Spyropoulou A, Tsartsara E, Aggeli A, Karveli S, et al. Schema therapy for patients with chronic depression: A single case series study. J Behav Ther Exp Psychiatry [Internet]. Elsevier Ltd; 2014;45:319–29. Available from: http://dx.doi.org/10.1016/j.jbtep.2014.02.003CrossRef

75.

Carter JD, McIntosh V V., Jordan J, Porter RJ, Frampton CM, Joyce PR. Psychotherapy for depression: A randomized clinical trial comparing schema therapy and cognitive behavior therapy. J Affect Disord [Internet]. Elsevier; 2013;151:500–5. Available from: http://dx.doi.org/10.1016/j.jad.2013.06.034CrossRef

76.

McGinn L, Young JE. Schema-focussed Therapy. In: Salkovskis PM, Rachman S, editors. Front Cogn Ther. Guilford; 1998. p. 554.

77.

Rosenzweig S. Some implicit common factors in diverse methods of psychotherapy. Am J Orthopsychiatry. US: American Orthopsychiatric Association, Inc.; 1936;6:412–5.CrossRef

78.

Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, Levitt JT, et al. The Dodo Bird Verdict Is Alive and Well-Mostly. Clin Psychol Sci Pract [Internet]. Wiley/Blackwell (10.1111); 2006 [cited 2018 Mar 19];9:2–12. Available from: http://doi.wiley.com/10.1093/clipsy.9.1.2CrossRef

79.

Budd R, Hughes I. The Dodo Bird Verdict-controversial, inevitable and important: a commentary on 30 years of meta-analyses. Clin Psychol Psychother [Internet]. 2009 [cited 2018 Mar 19];16:510–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19728292CrossRef

80.

Elliott K, Barker KK, Hunsley J. Dodo Bird Verdict in Psychotherapy. Encycl Clin Psychol [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2015 [cited 2018 Mar 19]. p. 1–5. Available from: http://doi.wiley.com/10.1002/9781118625392.wbecp053

81.

Cuijpers P. Are all psychotherapies equally effective in the treatment of adult depression? The lack of statistical power of comparative outcome studies. Evid Based Ment Heal [Internet]. 2016;ebmental-2016-102341. Available from: http://ebmh.bmj.com/lookup/doi/10.1136/eb-2016-102341

82.

Kazdin AE. Understanding how and why psychotherapy leads to change. Psychother Res [Internet]. Taylor & Francis Group; 2009 [cited 2018 Mar 20];19:418–28. Available from: http://www.tandfonline.com/doi/abs/10.1080/10503300802448899

83.

Lemmens LHJM, Müller VNLS, Arntz A, Huibers MJH. Mechanisms of change in psychotherapy for depression: An empirical update and evaluation of research aimed at identifying psychological mediators. Clin. Psychol. Rev. 2016.

Titel: Dritte Welle der Verhaltenstherapie
Klinische Wirksamkeit der Schematherapie bei Depressionen
verfasst von: Dr. med. Martin L. Rein
Dr. med. David Höhn
Prof. Dr. Dr. Martin E. Keck
Publikationsdatum: 11.12.2018
Verlag: Springer Medizin
Schlagwörter: Affektive Störungen
Affektive Störungen
Verhaltenstherapie
Erschienen in: NeuroTransmitter / Ausgabe 12/2018
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-018-6218-y

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

G-BA attestiert Zusatznutzen in der Indikation Schizophrenie

Kostenlos inserieren!

8-Jahres-Daten aus CARE-MS I und -II veröffentlicht

Irreversibler Ausfall der Hirnfunktion: Wann welche Diagnostik?

Vernetzung zahlt sich aus

Sichere Immunmodulation bei MS in Tablettenform